当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:187.72亿  总市值:188.74亿
流通股本:4.16亿   总股本:4.18亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,555,296,988.11726,174,326.793,608,810,283.532,221,551,326.83
  收到的税费返还--428,944.25428,944.25
  收到其他与经营活动有关的现金121,738,224.4354,979,606.38303,035,186.4216,310,532.78
  经营活动现金流入小计1,677,035,212.54781,153,933.173,912,274,414.182,438,290,803.86
  购买商品、接受劳务支付的现金1,027,674,586.25468,260,065.571,946,531,447.591,322,372,298.42
  支付给职工以及为职工支付的现金545,067,176.07288,309,965.331,056,596,892.61865,417,929.27
  支付的各项税费70,039,885.0742,735,734.05135,022,456.7794,872,008.8
  支付其他与经营活动有关的现金311,073,918.18163,201,724.33837,338,459.73592,301,658.12
  经营活动现金流出小计1,953,855,565.57962,507,489.283,975,489,256.72,874,963,894.61
  经营活动产生的现金流量净额-276,820,353.03-181,353,556.11-63,214,842.52-436,673,090.75
二、投资活动产生的现金流量:
  收回投资收到的现金3,202,083,632.231,715,836,006.296,011,331,867.584,693,110,320.32
  取得投资收益收到的现金30,911,201.4116,513,434.4273,316,859.5457,450,047.01
  处置固定资产、无形资产和其他长期资产收回的现金净额29,366,640.9365,380.476,054,606.513,529,744.89
  处置子公司及其他营业单位收到的现金净额6.926.92--
  收到的其他与投资活动有关的现金186,184.43---
  投资活动现金流入小计3,262,547,665.891,732,714,828.16,090,703,333.634,754,090,112.22
  购建固定资产、无形资产和其他长期资产支付的现金237,155,791.91173,315,399.68505,923,268.2275,362,984.95
  投资支付的现金3,113,651,762.81,473,589,292.966,597,967,366.825,237,461,623.8
  支付其他与投资活动有关的现金186,184.43-12,001,775.7312,001,775.73
  投资活动现金流出小计3,350,993,739.141,646,904,692.647,115,892,410.755,524,826,384.48
  投资活动产生的现金流量净额-88,446,073.2585,810,135.46-1,025,189,077.12-770,736,272.26
三、筹资活动产生的现金流量:
  取得借款收到的现金--570,960,000570,960,000
  收到其他与筹资活动有关的现金33,825,689.76-69,200,21569,200,215
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计33,825,689.76-640,160,215640,160,215
  偿还债务支付的现金62,398,00028,898,000434,441,873.18418,441,873.18
  分配股利、利润或偿付利息支付的现金7,313,192.853,708,331.3517,284,157.5513,440,306.28
  支付其他与筹资活动有关的现金27,128,470.18,167,141.9338,575,658.0428,233,401.78
  筹资活动现金流出小计96,839,662.9540,773,473.28490,301,688.77460,115,581.24
  筹资活动产生的现金流量净额-63,013,973.19-40,773,473.28149,858,526.23180,044,633.76
四、汇率变动对现金及现金等价物的影响-29,901,643.04-17,034,709.79-1,550,675.117,022,116.61
五、现金及现金等价物净增加额-458,182,042.51-153,351,603.72-940,096,068.52-1,020,342,612.64
  加:期初现金及现金等价物余额1,758,430,546.181,758,321,155.882,698,417,224.42,698,417,224.4
  期末现金及现金等价物余额1,300,248,503.671,604,969,552.161,758,321,155.881,678,074,611.76
补充资料:
  净利润47,779,923.37--637,805,702.62-
  资产减值准备94,456,667.79-485,627,267.37-
  固定资产和投资性房地产折旧178,698,850.6-408,396,255.92-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧178,698,850.6-408,396,255.92-
  无形资产摊销37,351,994.44-76,038,256.62-
  长期待摊费用摊销15,522,331.79-49,510,967.53-
  处置固定资产、无形资产和其他长期资产的损失-1,480,692.69-336,061.07-
  固定资产报废损失1,301,560.52-4,356,878.64-
  公允价值变动损失-25,192,564.11-11,291,407.29-
  财务费用-13,353,810.81--16,866,315.43-
  投资损失5,674,466.99--12,957,568.69-
  递延所得税-3,943,602.9--14,018,941.29-
  其中:递延所得税资产减少-7,898,480.43--5,550,624.09-
    递延所得税负债增加3,954,877.53--8,468,317.2-
  存货的减少-26,725,973.74-86,419,672.02-
  经营性应收项目的减少-324,862,234.34--244,438,338.19-
  经营性应付项目的增加-276,984,281.39--234,769,844.39-
  其他---57,852,628.01-
  不涉及现金收支的投资和筹资活动金额其他项目4,969,180.66-65,287,712.95-
  现金的期末余额1,300,248,503.67-1,758,321,155.88-
  减:现金的期初余额1,758,430,546.18-2,698,417,224.4-
  现金及现金等价物的净增加额-458,182,042.51--940,096,068.52-
公告日期2026-08-222026-04-252026-04-252025-10-24
审计意见(境内)标准无保留意见
TOP↑